Skip to main content
Clinical Trials/NL-OMON44188
NL-OMON44188
Completed
Not Applicable

Pilot study: Respiratory microbiome analysis by the IS-pro technology - The Maastricht Respiratory Microbiome Study

Medisch Universitair Ziekenhuis Maastricht0 sites21 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
community of microorganisms
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
21
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 17, 2017
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \* Diagnosis of COPD stages I\-IV, class A\-D, as defined by the Global initiative for chronic Obstructive Lung Disease (GOLD);
  • \* Patients must be planned to undergo a bronchoscopy;
  • \* Patients must be able to complete questionnaires;
  • \* Patients must sign and date an informed consent prior to inclusion.

Exclusion Criteria

  • \* Chronic use of oral corticosteroids \> 10 mg/day;
  • \* Investigator\*s uncertainty about the willingness or ability of the patient to comply with the protocol requirements, e.g. not smoking 6 hours before and fasting two hours before sputum induction;
  • \* Patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study;
  • \* Patients unlikely to comply with the protocol, e.g. uncooperative attitude, and unlikelihood of completing the study (not able to attend all three visits).

Outcomes

Primary Outcomes

Not specified

Similar Trials